Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development
10.1038/35009138
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Gao, Y., Ferguson, D. O., Xie, W., Manis, J. P., Sekiguchi, J., Frank, K. M., Chaudhuri, J., Horner, J., DePinho, R. A., & Alt, F. W. (2000). Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature, 404(6780), 897–900.

Authors 10
  1. Yijie Gao (first)
  2. David O. Ferguson (additional)
  3. Wei Xie (additional)
  4. John P. Manis (additional)
  5. JoAnn Sekiguchi (additional)
  6. Karen M. Frank (additional)
  7. Jayanta Chaudhuri (additional)
  8. James Horner (additional)
  9. Ronald A. DePinho (additional)
  10. Frederick W. Alt (additional)
References 25 Referenced 464
  1. Li,Z. et al. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 83, 1079–1089 (1995). (10.1016/0092-8674(95)90135-3) / Cell by Z Li (1995)
  2. Gao,Y. et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95, 891– 902 (1998). (10.1016/S0092-8674(00)81714-6) / Cell by Y Gao (1998)
  3. Levine,A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997). (10.1016/S0092-8674(00)81871-1) / Cell by AJ Levine (1997)
  4. Jeggo,P. A. Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat. Res. 150, S80– 91 (1998). (10.2307/3579810) / Radiat. Res. by PA Jeggo (1998)
  5. Lieber,M. R. The biochemistry and biological significance of nonhomologous DNA end joining: an essential repair process in multicellular eukaryotes. Genes Cells 4, 77–85 ( 1999). (10.1046/j.1365-2443.1999.00245.x) / Genes Cells by MR Lieber (1999)
  6. Takata,M. et al. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17, 5497–5508 (1998). (10.1093/emboj/17.18.5497) / EMBO J. by M Takata (1998)
  7. Gellert,M. Recent advances in understanding V(D)J recombination. Adv. Immunol. 64, 39–64 ( 1997). (10.1016/S0065-2776(08)60886-X) / Adv. Immunol. by M Gellert (1997)
  8. Barnes,D. E., Stamp,G., Rosewell,I., Denzel,A. & Lindahl,T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr. Biol. 8 , 1395–1398 (1998). (10.1016/S0960-9822(98)00021-9) / Curr. Biol. by DE Barnes (1998)
  9. Frank,K. M. et al. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 396, 173–177 (1998). (10.1038/24172) / Nature by KM Frank (1998)
  10. Gu,Y. et al. Defective embryonic neurogenesis in Ku, but not DNA-PKcs, deficient mice. Proc. Natl Acad. Sci. USA 97, 2668 –2673 (2000). (10.1073/pnas.97.6.2668) / Proc. Natl Acad. Sci. USA by Y Gu (2000)
  11. Jiang,D., Lenardo,M. J. & Zuniga-Pflucker, C. p53 prevents maturation to the CD4+CD8+ stage of thymocyte differentiation in the absence of T-cell receptor rearrangement. J. Exp. Med. 183, 1923–1928 (1996). (10.1084/jem.183.4.1923) / J. Exp. Med. by D Jiang (1996)
  12. Guidos,C. J. et al. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10, 2038–2054 (1996). (10.1101/gad.10.16.2038) / Genes Dev. by CJ Guidos (1996)
  13. Bogue,M. A., Zhu,C., Aguilar-Cordova,E., Donehower,L. A. & Roth,D. B. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 10, 553–565 (1996). (10.1101/gad.10.5.553) / Genes Dev. by MA Bogue (1996)
  14. Liyanage,M. et al. Multicolour spectral karyotyping of mouse chromosomes. Nature Genet. 14, 312–315 (1996). (10.1038/ng1196-312) / Nature Genet. by M Liyanage (1996)
  15. Karanjawala,Z. E., Grawunder,U., Hsieh,C. L. & Lieber,M. R. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 9, 1501 –1504 (1999). (10.1016/S0960-9822(00)80123-2) / Curr. Biol. by ZE Karanjawala (1999)
  16. Paulson,T. G., Almasan,A., Brody,L. L. & Wahl,G. M. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol. Cell. Biol. 18, 3089–3100 (1998). (10.1128/MCB.18.5.3089) / Mol. Cell. Biol. by TG Paulson (1998)
  17. Vanasse,G. J. et al. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J. Clin. Invest. 103, 1669–1675 (1999). (10.1172/JCI6658) / J. Clin. Invest. by GJ Vanasse (1999)
  18. Liao,M. J. et al. No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol. Cell. Biol. 18, 3495– 3501 (1998). (10.1128/MCB.18.6.3495) / Mol. Cell. Biol. by MJ Liao (1998)
  19. Nacht,M. et al. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10, 2055–2066 (1996). (10.1101/gad.10.16.2055) / Genes Dev. by M Nacht (1996)
  20. Rabbitts,T. H. Chromosomal translocations in human cancer. Nature 372, 143–149 (1994). (10.1038/372143a0) / Nature by TH Rabbitts (1994)
  21. Malynn,B. A. et al. The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 54, 453– 460 (1988). (10.1016/0092-8674(88)90066-9) / Cell by BA Malynn (1988)
  22. Hiom,K., Melek,M. & Gellert,M. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell 94, 463–470 (1998). (10.1016/S0092-8674(00)81587-1) / Cell by K Hiom (1998)
  23. Agrawal,A., Eastman,Q. M. & Schatz, D. G. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394, 744–751 (1998). (10.1038/29457) / Nature by A Agrawal (1998)
  24. Jacks,T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1–7 ( 1994). (10.1016/S0960-9822(00)00002-6) / Curr. Biol. by T Jacks (1994)
  25. Bieche,I. et al. Novel approach to quantitative polymerase chain reaction using real- time detection: application to the detection of gene amplification in breast cancer. Int. J. Cancer 78, 661– 666 (1998). (10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.0.CO;2-I) / Int. J. Cancer by I Bieche (1998)
Dates
Type When
Created 22 years, 11 months ago (Sept. 13, 2002, 12:36 p.m.)
Deposited 2 years, 3 months ago (May 16, 2023, 9:54 p.m.)
Indexed 2 months, 3 weeks ago (June 5, 2025, 6:23 p.m.)
Issued 25 years, 4 months ago (April 1, 2000)
Published 25 years, 4 months ago (April 1, 2000)
Published Print 25 years, 4 months ago (April 1, 2000)
Funders 0

None

@article{Gao_2000, title={Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development}, volume={404}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/35009138}, DOI={10.1038/35009138}, number={6780}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Gao, Yijie and Ferguson, David O. and Xie, Wei and Manis, John P. and Sekiguchi, JoAnn and Frank, Karen M. and Chaudhuri, Jayanta and Horner, James and DePinho, Ronald A. and Alt, Frederick W.}, year={2000}, month=apr, pages={897–900} }